Inspira Pharmaceuticals: Revision history

20 August 2022

• curprev 04:4704:47, 20 August 2022‎ 95.149.241.133 talk‎ 3,493 bytes +11‎ No edit summary undo Tag: Visual edit: Switched

22 July 2022

• curprev 18:4618:46, 22 July 2022‎ Louis talk contribs‎ 3,482 bytes +42‎ No edit summary undo Tag: Visual edit

17 May 2022

• curprev 17:0317:03, 17 May 2022‎ 172.18.0.3 talk‎ 3,440 bytes −222‎ →‎Idea undo

5 April 2022

• curprev 09:5009:50, 5 April 2022‎ 94.119.64.2 talk‎ 3,662 bytes +15‎ →‎Idea undo
• curprev 09:4909:49, 5 April 2022‎ 94.119.64.2 talk‎ 3,647 bytes +3,647‎ Created page with "==Summary== Inspira Pharma is developing a potential new therapy for COVID-19. The active molecules being tested are plant-based and have shown an ability to destroy the SARS-CoV-2 virus in the lab. Funds raised will be used to test clinical formulations and prove safety and efficacy in humans. * Patent protected plant-based formulations (under license) * Proven to kill SARS-CoV-2 in early stage lab testing * Platform technology - Potential for a range of lung diseases..."